EQT

News

Oxford BioMedica confirmed this morning that it has received an unsolicited approach from private equity group EQT about a possible takeover.

News

BioNTech's vaccine for head and neck cancer has failed a clinical trial, but it will wait for more data before deciding the programme's fate.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.